<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=875423625897521&amp;ev=PageView&amp;noscript=1">

Get Fresh Updates on Email

We'll never share your email address and you can opt out at any time, we promise

Kidney Care News to Know

FDA Grants Fresenius Medical Care’s Hemodialysis System Breakthrough Device Status

The new Fresenius system is designed to prevent blood clotting without the use of blood thinners by adding Endexo, an anti-thrombogenic additive, to the manufacturing process of the dialyzers and bloodlines..

Source: Nephrology News & Issues

kidney care news-3

ICU Medical Acquires Pursuit Vascular

The definitive agreement sees ICU Medical acquiring Pursuit Vascular for $75 million. ICU Medical leaders say Pursuit Vascular’s ClearGuard HD cap, used for the maintenance of hemodialysis catheters, will be a great fit for the company’s portfolio of products.

Source: Nephrology News & Issues

Recovery Time After Dialysis Impacted by Patient, Demographic and Clinical Factors

Researchers found longer recovery times were associated with catheter use, lower albumin, sodium and intact parathyroid hormone levels; lower Kt/V, ultrafiltration volume by body weight, ultrafiltration rates and treatment frequency. Treatment time, phosphate levels and interdialytic weight gain did not appear to affect recovery time, researchers noted.

Source: Nephrology News & Issues

New Research: Percutaneous Device for Dialysis Access has Excellent Patency Rates

In a study, clinicians used a proximal radial artery (PRA)-AVF method to create an access along with the Ellipsys Vascular Access System. The study found that the percutaneous dialysis access device has excellent cumulative patency rates up to two years and has high patient satisfaction rates.

Source: Medscape

ESRD Patients at Higher Risk for Contracting Syphilis

Researchers found ESRD patients had a three times greater incidence of being diagnosed with syphilis than the general population.

Source: Renal & Urology News

Regular Blood Testing for HD Patients Not Associated with Lower Risks

A new study reveals routine monthly blood testing for prevalent patients on hemodialysis is not associated with a lower risk of death, cardiovascular events, hospitalization or hyperkalemia compared with blood testing performed every six weeks.

Source: Renal & Urology News

Depression Linked to Non-adherence to Dietary Recommendations

Researchers found a high prevalence and significant correlation between depression and not adhering to dietary advice in hemodialysis patients.

Source: Nephrology News & Issues

New call-to-action

New call-to-action